IMATINIB MESYLATE - Generic Cancer Medicine India
Imatinib Mesylate is a protein-tyrosine kinase inhibitor, an antineoplastic (anticancer) drug. Imatinib is approved for the treatment of certain types of cancer such as Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia (CML), Gastrointestinal Stromal Tumors. It should be used only under specialist supervision.
Imatinib is taken either once or twice daily, depending on the dose.
Imatinib 100 mg is different from traditional chemotherapy in that it is very selective. Traditional chemotherapy kills all cells that are dividing quickly. This is what causes so many of the side effects of traditional chemotherapy. In addition to the cancer cells, this type of chemotherapy also kills many of the body’s normal cells.
Veenat 100 mg Capsules is much more selective and as a result has fewer side effects. It is designed to block the activity of a mutant type of enzyme (an enzyme is a specific type of protein) that causes Chronic Myeloid Leukemia (CML).
Veenat comes in two strength -
Veenat is an effective treatment that has been approved in many countries for GIST.
Contraindications
Imatinib Mesylate is contraindicated in conditions like Breast feeding.
Side Effects
The symptomatic adverse reactions produced by Generic Imatinib 400 mg Natco are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Fatigue, Anorexia, Skin reactions, Insomnia, Dry mouth, Muscle cramps, Pyrexia, Lacrimation, Dry cough, Taste disturbances, Paresthesias, GI disturbance, Ulceration, CNS disturbances, Dry mouth, GI bleeding, influenza, dizziness, Dyspnoea.
High Risk Groups
Drug should not be given to Pregnant Mothers.
Imatinib Mesylate is a protein-tyrosine kinase inhibitor, an antineoplastic (anticancer) drug. Imatinib is approved for the treatment of certain types of cancer such as Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia (CML), Gastrointestinal Stromal Tumors. It should be used only under specialist supervision.
Imatinib is taken either once or twice daily, depending on the dose.
Imatinib 100 mg is different from traditional chemotherapy in that it is very selective. Traditional chemotherapy kills all cells that are dividing quickly. This is what causes so many of the side effects of traditional chemotherapy. In addition to the cancer cells, this type of chemotherapy also kills many of the body’s normal cells.
Veenat 100 mg Capsules is much more selective and as a result has fewer side effects. It is designed to block the activity of a mutant type of enzyme (an enzyme is a specific type of protein) that causes Chronic Myeloid Leukemia (CML).
Veenat comes in two strength -
- 400 mg as Tablets and
- 100 mg Capsules
Veenat is an effective treatment that has been approved in many countries for GIST.
Contraindications
Imatinib Mesylate is contraindicated in conditions like Breast feeding.
Side Effects
The symptomatic adverse reactions produced by Generic Imatinib 400 mg Natco are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Fatigue, Anorexia, Skin reactions, Insomnia, Dry mouth, Muscle cramps, Pyrexia, Lacrimation, Dry cough, Taste disturbances, Paresthesias, GI disturbance, Ulceration, CNS disturbances, Dry mouth, GI bleeding, influenza, dizziness, Dyspnoea.
High Risk Groups
Drug should not be given to Pregnant Mothers.